Systemic Myasthenia Gravis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-10-11
Clinical Trial Update: A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis [Phase 2]
Phase 2 trial update for RC18 antibody fusion protein targeting systemic myasthenia gravis has completed.